Peng-Yu Zhang
Overview
Explore the profile of Peng-Yu Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
554
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Feng Y, Du J, Chen H, Shen Y, Jia Y, Zhang P, et al.
Sci Rep
. 2024 Oct;
14(1):23743.
PMID: 39390242
Hematological malignancies are a group of cancers that affect the blood, bone marrow, and lymphatic system. Cancer stem cells (CSCs) are believed to be responsible for the initiation, progression, and...
2.
Li L, Ren D, Zhang P, Song Y, Li T, Gao M, et al.
Anal Chem
. 2024 Jun;
96(25):10356-10364.
PMID: 38863415
Capillary electrophoresis with capacitively coupled contactless conductivity detection (CE-CD) has proven to be an efficient technique for the separation and detection of charged inorganic, organic, and biochemical analytes. It offers...
3.
Wang Q, Zhang P, Li Q, Tong Z, Wu J, Yu S, et al.
Eur J Med Chem
. 2023 May;
257:115464.
PMID: 37235998
Glioma is one of the most common types of brain tumors, and its high recurrence and mortality rates threaten human health. In 2008, the frequent isocitrate dehydrogenase 1 (IDH1) mutations...
4.
Wang B, Zhao W, Chen Y, Cao X, Yang Y, Zhang Y, et al.
J Med Case Rep
. 2022 Dec;
16(1):459.
PMID: 36496425
Background: Multiple myeloma remains incurable despite treatment advancements over the last 20 years. LCAR-B38M Cells in Treating Relapsed/Refractory Multiple Myeloma was a phase 1, first-in-human, investigator-initiated study in relapsed/refractory multiple...
5.
Huang Y, Xu Z, Zhao L, Cao Y, Chen Y, Qiu Y, et al.
World J Clin Cases
. 2022 Jul;
10(16):5266-5274.
PMID: 35812664
Background: Venoarterial extracorporeal membrane oxygenation (VA-ECMO) offers hemodynamic support for patients undergoing high-risk percutaneous coronary interventions (PCIs). However, long-term outcomes associated with VA-ECMO have not previously been studied. Aim: To...
6.
Zhao W, Wang B, Chen L, Fu W, Xu J, Liu J, et al.
J Hematol Oncol
. 2022 Jul;
15(1):86.
PMID: 35794616
Background: LCAR-B38M is a chimeric antigen receptor T cell product with two binding domains targeting B cell maturation antigen. Our previous reports showed a remarkable efficacy of LCAR-B38M in patients...
7.
Ding F, Feng Y, Han L, Zhou Y, Ji Y, Hao H, et al.
Front Public Health
. 2021 Sep;
9:712190.
PMID: 34513787
Fever is one of the typical symptoms of coronavirus disease (COVID-19). We aimed to investigate the association between early fever (EF) and clinical outcomes in COVID-19 patients. A total of...
8.
Zhang P, Qiu X, Fu J, Wang G, Wei L, Wang T
Physiol Mol Biol Plants
. 2021 Jun;
27(6):1295-1309.
PMID: 34177148
Supplementary Information: The online version contains supplementary material available at 10.1007/s12298-021-01013-2.
9.
Lei B, Zhang W, He A, Chen Y, Cao X, Zhang P, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2019 Oct;
27(5):1463-1468.
PMID: 31607299
Objective: To investigate the transcriptional regulation of transcription factor MZF-1 on acute monocytic leukemia-related gene MLAA-34. Methods: The effect of MZF-1 on the transcriptional activity of MLAA-34 gene promoter was...
10.
Lei B, Zhang W, He A, Chen Y, Cao X, Zhao W, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2019 Jun;
27(3):641-645.
PMID: 31204911
Objective: To clone the promoter sequence of acute monocytic leukemia new antigen gene.MLAA-34 and identify its promoter core region. Methods: The full-length fragment of MLAA-34 gene promoter region was amplified...